Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biomarin Pharmaceutical Inc

BMRN
Current price
90.47 USD -0.67 USD (-0.74%)
Last closed 90.87 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 17 501 050 880 USD
Yield for 12 month -8.07 %
1Y
3Y
5Y
10Y
15Y
BMRN
21.11.2021 - 28.11.2021

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California. Address: 770 Lindaro Street, San Rafael, CA, United States, 94901

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

109.48 USD

P/E ratio

106

Dividend Yield

Current Year

+2 419 226 000 USD

Last Year

+2 096 039 000 USD

Current Quarter

+646 207 000 USD

Last Quarter

+585 965 000 USD

Current Year

+1 842 161 000 USD

Last Year

+1 612 370 000 USD

Current Quarter

+510 729 000 USD

Last Quarter

+445 539 000 USD

Key Figures BMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 276 483 008 USD
Operating Margin TTM 4.37 %
PE Ratio 106
Return On Assets TTM 1.63 %
PEG Ratio 0.7601
Return On Equity TTM 3.51 %
Wall Street Target Price 109.48 USD
Revenue TTM 2 419 226 112 USD
Book Value 26.25 USD
Revenue Per Share TTM 12.88 USD
Dividend Share
Quarterly Revenue Growth YOY 20.2 %
Dividend Yield
Gross Profit TTM 1 612 370 000 USD
Earnings Share 0.87 USD
Diluted Eps TTM 0.87 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 98 %
Profit Margin 6.93 %

Dividend Analytics BMRN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 106
Forward PE 34.3643
Enterprise Value Revenue 7.2456
Price Sales TTM 7.2342
Enterprise Value EBITDA 56.6008
Price Book MRQ 3.5356

Financials BMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BMRN

For 52 weeks

76.02 USD 100.31 USD
50 Day MA 87.47 USD
Shares Short Prior Month 2 964 290
200 Day MA 88.96 USD
Short Ratio 2.39
Shares Short 3 064 453
Short Percent 1.63 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds


M

MDAXEX

208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics

Metals


Gold

2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics